Beta-lactam antibiotics represent a class of drugs with a wide spectrum of antibacterial activity. Hospira said that Meropenem represents the first US drug launch from its recent acquisition of the generic injectables business of Orchid Chemicals & Pharmaceuticals.
Thomas Moore, president of Hospira for US region, said: “This is the first generic carbapenem approved in the US. Hospira is committed to continuing to reduce the cost of healthcare spending by providing savings with first-to-market generic launches.”
Hospira’s specialty injectable pharmaceuticals (SIP) offering includes approximately 200 generic injectable drugs in many dosages and formulations. Hospira offers portfolio of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions.